We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXPR
676
DELISTED
Express, Inc.
EXPR
| $564K | 0.01% |
4,180
+900
| +27% | +$140K |
|
677
Vera Bradley
VRA
$105M
| $561K | 0.01% |
57,400
+8,000
| +16% | +$70K |
|
|
BDSI
678
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $560K | 0.01% |
+200,049
| New | +$422K |
|
679
Enterprise Financial Services Corp
EFSC
$2.41B
| $558K | 0.01% |
13,680
+8,500
| +164% | +$354K |
|
|
INFI
680
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $556K | 0.01% |
353,891
-37,780
| -10% | -$72.9K |
|
681
Financial Institutions
FISI
$800M
| $555K | 0.01% |
18,621
+7,220
| +63% | +$229K |
|
|
LSXMA
682
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $554K | 0.01% |
+18,271
| New | +$521K |
|
|
VVUS
683
DELISTED
Vivus Inc
VVUS
| $550K | 0.01% |
45,076
+27,296
| +154% | +$300K |
|
|
MXWL
684
DELISTED
Maxwell Technologies Inc
MXWL
| $545K | 0.01% |
90,914
+11,066
| +14% | +$64.4K |
|
|
DCH
685
Dauch Corp
DCH
$1.3B
| $542K | 0.01% |
34,743
-123,450
| -78% | -$2.01M |
|
686
Strategic Education
STRA
$1.71B
| $538K | 0.01% |
5,770
+110
| +2% | +$9.65K |
|
687
BOK Financial
BOKF
$8.64B
| $533K | 0.01% |
+6,340
| New | +$517K |
|
688
Valmont Industries
VMI
$9.44B
| $531K | 0.01% |
+3,551
| New | +$534K |
|
689
WSFS Financial
WSFS
$4.16B
| $528K | 0.01% |
11,645
+560
| +5% | +$25.6K |
|
690
Allient
ALNT
$1.47B
| $526K | 0.01% |
29,001
-1,713
| -6% | -$28.3K |
|
691
QCR Holdings
QCRH
$1.65B
| $525K | 0.01% |
+11,067
| New | +$498K |
|
692
Group 1 Automotive
GPI
$3.94B
| $524K | 0.01% |
8,280
-20,210
| -71% | -$1.3M |
|
693
Chemours
CC
$2.59B
| $520K | 0.01% |
+13,710
| New | +$541K |
|
|
SRGA
694
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $520K | 0.01% |
2,964
+610
| +26% | +$86.8K |
|
695
Lincoln Electric
LECO
$13.8B
| $511K | 0.01% |
+5,550
| New | +$499K |
|
696
Lantheus
LNTH
$6.82B
| $511K | 0.01% |
28,928
| – | – |
|
|
CEMP
697
DELISTED
Cempra, Inc.
CEMP
| $510K | 0.01% |
+110,800
| New | +$438K |
|
|
GUID
698
DELISTED
Guidance Software, Inc.
GUID
| $506K | 0.01% |
76,521
+13,100
| +21% | +$83K |
|
699
Plexus
PLXS
$6.81B
| $500K | 0.01% |
9,510
-3,210
| -25% | -$170K |
|
700
Arista Networks
ANET
$219B
| $495K | 0.01% |
+52,864
| New | +$479K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.